forphenicinol has been researched along with Pulmonary Consumption in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishibashi, T; Shinoda, A; Sugiyama, K; Takamoto, M | 1 |
| Ishibashi, T; Kawakami, K; Kihara, H; Nagano, H; Nakanishi, K; Otsu, T; Shinoda, A; Takamoto, M; Yamamoto, T; Yamato, Y | 1 |
1 trial(s) available for forphenicinol and Pulmonary Consumption
| Article | Year |
|---|---|
[Clinical trial of forphenicinol for the lung infection with Mycobacterium avium, Mycobacterium intracellulare complex].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clinical Trials as Topic; Female; Glycine; Humans; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 1987 |
1 other study(ies) available for forphenicinol and Pulmonary Consumption
| Article | Year |
|---|---|
[Fundamental and clinical studies on forphenicinol, a small-molecular immunomodulator].
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Glycine; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 1984 |